Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03341156 · ClinicalTrials.gov registry record · Phase 3
Administration of Prothrombin Complex Concentrate vs. Standard Transfusion During/After Heart Transplantation
A Phase 3 study, sponsored by University of Maryland, Baltimore.
- Terminated
- Registry status
- Phase 3
- Development phase
- 14
- Enrollment target
NCT03341156 is a Phase 3 study that was terminated before completion, run by University of Maryland, Baltimore. The registered enrollment target is 14 participants.
The verdict
NCT03341156, a Phase 3 study, was terminated before completion, sponsored by University of Maryland, Baltimore.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study is comparing the use of Kcentra vs. standard transfusion in patients undergoing heart transplantation surgery. Half of the patients will receive Kcentra, while the other half will receive fresh frozen plasma.
Interventions
- DRUG Kcentra
- DRUG Frozen Plasma Product, Human
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2018-07-11 |
| Est. Completion | 2025-02-20 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03341156
The ClinicalTrials.gov registry entry for NCT03341156 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Kcentra is the first listed.
NCT03341156 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03341156 about?
NCT03341156 is a clinical study titled "Administration of Prothrombin Complex Concentrate vs. Standard Transfusion During/After Heart Transplantation". This study is comparing the use of Kcentra vs. standard transfusion in patients undergoing heart transplantation surgery. Half of the patients will receive Kcentra, while the other half will receive fresh frozen plasma.
What is the current status of trial NCT03341156?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 14 participants. The study started on 2018-07-11. Estimated completion is 2025-02-20.
What interventions are being tested in trial NCT03341156?
The interventions under investigation include: Kcentra (DRUG), Frozen Plasma Product, Human (DRUG).
Who is sponsoring clinical trial NCT03341156?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.